This is not about "pharma" though, where "pharma" means pharmaceutical companies. There is nothing of any interest in aspirin for commercial pharmaceutical org

This is not about "pharma" though, where "pharma" means pharmaceutical companies. There is nothing of any interest in aspirin for commercial pharmaceutical organizations - any money spent in research is not recoverable. They will of course focus their efforts on researching new drugs, as their shareholders would expect.